Comparative effectiveness study of single high-dose cisplatin with fractionated doses cisplatin in first-line therapy for treatment-naive Chinese patients with advanced non–small-cell lung cancer

Current Problems in Cancer ◽

10.1016/j.currproblcancer.2019.01.007 ◽

2019 ◽

Vol 43 (6) ◽

pp. 100466 ◽

Author(s):

Xiaoyou Li ◽

Xia Zhao ◽

Muhammad Abbas ◽

Li Wang ◽

Chenchen Li ◽

...

Keyword(s):

Comparative Effectiveness ◽

Chinese Patients ◽

High Dose ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Comparative Effectiveness Study ◽

Treatment Naïve

Download Full-text

Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China

Clinical Therapeutics ◽

10.1016/j.clinthera.2019.02.004 ◽

2019 ◽

Vol 41 (3) ◽

pp. 518-529 ◽

Author(s):

Xiaoyou Li ◽

Muhammad Abbas ◽

Yun Li ◽

Yue Teng ◽

Ying Fang ◽

...

Keyword(s):

Lung Cancer ◽

Comparative Effectiveness ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Treatment Naïve ◽

Doublet Chemotherapy ◽

Platinum Doublet

Download Full-text

Comparative effectiveness study of first-line pemetrexed-platinum doublet chemotherapy with or without bevacizumab for Chinese patients with advanced non-squamous non-small-cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e21053 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e21053-e21053

Author(s):

Xiaoyou Li ◽

Li Wang ◽

Yi Wen ◽

Meiqi Shi

Keyword(s):

Lung Cancer ◽

Comparative Effectiveness ◽

Chinese Patients ◽

Effectiveness Study ◽

Small Cell Lung ◽

Comparative Effectiveness Study ◽

Doublet Chemotherapy ◽

Platinum Doublet

Download Full-text

Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study

Thoracic Cancer ◽

10.1111/1759-7714.14079 ◽

2021 ◽

Author(s):

Zhansheng Jiang ◽

Jing Zhang ◽

Haiyan Sun ◽

Cong Wang ◽

Yu Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Retrospective Study ◽

Small Cell Lung Cancer ◽

Chinese Patients ◽

Egfr Mutations ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

6563 POSTER High-dose 130-nanometer albumin-bound paclitaxel in combination with carboplatin as first-line therapy in advanced non-small cell lung cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71391-5 ◽

2007 ◽

Vol 5 (4) ◽

pp. 376-377

Author(s):

M.J. Hawkins ◽

M. Georgy ◽

A. Makhson ◽

S. Cheporov ◽

O. Sergey ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

High Dose ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer

Biomedicine & Pharmacotherapy ◽

10.1016/j.biopha.2013.04.013 ◽

2013 ◽

Vol 67 (8) ◽

pp. 763-769 ◽

Author(s):

Bei Xu ◽

Peng Liu ◽

Yongmei Yin ◽

Ping Liu ◽

Yongqian Shu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chinese Patients ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

Real world study of regimen containing bevacizumab as first-line therapy in Chinese patients with advanced non-small cell lung cancer

Thoracic Cancer ◽

10.1111/1759-7714.12650 ◽

2018 ◽

Vol 9 (7) ◽

pp. 805-813 ◽

Author(s):

Puyuan Xing ◽

Yuxin Mu ◽

Yan Wang ◽

Xuezhi Hao ◽

Yixiang Zhu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chinese Patients ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Safety And Efficacy ◽

First Line Therapy ◽

Download Full-text

112P Atezolizumab as first-line therapy for patients with advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01954-7 ◽

2021 ◽

Vol 16 (4) ◽

pp. S759

Author(s):

E. Marcella ◽

B. Susanto ◽

S. Chen ◽

J. Tandiono ◽

A. Tancherla ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

First Line Therapy ◽

Download Full-text

6519 ORAL Favorable benefit to risk profile for pemetrexed plus cisplatin versus gemcitabine plus cisplatin in a large phase III study of first-line therapy in advanced non-small cell lung cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71347-2 ◽

2007 ◽

Vol 5 (4) ◽

pp. 363 ◽

Author(s):

G. Scagliotti ◽

K. Park ◽

S. Patil ◽

J. Rolski ◽

T. Gorksel ◽

...

Keyword(s):

Lung Cancer ◽

Risk Profile ◽

Phase Iii ◽

Small Cell Lung ◽

First Line Therapy ◽

Line Therapy ◽

Phase Iii Study ◽

Download Full-text

PCN245 Examining Longitudinal Practice Patterns in the use of ANTI-PD-1 and ANTI-PD-L1 Inhibitors as First-Line Therapy in Non-Small Cell Lung Cancer Patients in the US

Value in Health ◽

10.1016/j.jval.2021.04.335 ◽

2021 ◽

Vol 24 ◽

pp. S65-S66

Author(s):

R. Veluswamy ◽

G. Barnes ◽

R. Strauss ◽

D. Harrough ◽

B. Tang

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Practice Patterns ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

First Line Therapy ◽

Line Therapy ◽

Download Full-text